4 analysts offer recommendations for Design Therapeutics Inc (DSGN) stock

The price of Design Therapeutics Inc (NASDAQ: DSGN) closed at $2.23 in the last session, up 0.45% from day before closing price of $2.22. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 721292 shares were traded. DSGN stock price reached its highest trading level at $2.2680 during the session, while it also had its lowest trading level at $2.1800.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.



We take a closer look at DSGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 23.77 and its Current Ratio is at 23.77. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on November 14, 2023, Downgraded its rating to Neutral and sets its target price to $6 from $42 previously.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 29 when LAPPE RODNEY W bought 21,000 shares for $2.35 per share. The transaction valued at 49,287 led to the insider holds 133,024 shares of the business.

William Arsani bought 1,960,000 shares of DSGN for $4,782,400 on Aug 29. The Director now owns 3,000,000 shares after completing the transaction at $2.44 per share. On Aug 29, another insider, Prasad Deepa, who serves as the Director of the company, bought 12,000 shares for $2.31 each. As a result, the insider paid 27,670 and bolstered with 23,806 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 124.32M and an Enterprise Value of -163.40M.

Stock Price History:

Over the past 52 weeks, DSGN has reached a high of $15.52, while it has fallen to a 52-week low of $1.94. The 50-Day Moving Average of the stock is 2.2631, while the 200-Day Moving Average is calculated to be 5.1030.

Shares Statistics:

According to the various share statistics, DSGN traded on average about 688.14K shares per day over the past 3-months and 698.05k shares per day over the past 10 days. A total of 55.90M shares are outstanding, with a floating share count of 32.56M. Insiders hold about 41.86% of the company’s shares, while institutions hold 47.55% stake in the company. Shares short for DSGN as of Oct 30, 2023 were 3.12M with a Short Ratio of 3.12M, compared to 2.92M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.57% and a Short% of Float of 9.26%.

Earnings Estimates

The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.31 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.38, while EPS last year was -$0.31. The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.27 and low estimates of -$0.43.

Analysts are recommending an EPS of between -$1.27 and -$1.37 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.4, with 4 analysts recommending between -$1.05 and -$1.86.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular